RESPONSE PHARMACEUTICALS, INC.

Profile

Company Names

RESPONSE PHARMACEUTICALS, INC.

Addresses

1104 WEST BROAD STREET #1064, FALLS CHURCH, VA 22046

902 TURKEY RUN ROAD, MCLEAN, VA 22101

Phone Numbers

703-624-2024

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$11,886,635.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2024-06-13 
$3,898,385.00 
$5,000,000.00 
$1,101,615.00 
Debt 
1
2022-02-08 
$7,988,250.00 
$8,000,000.00 
$11,750.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
 
BERENDT 
DIRECTOR
RETENSION PHARMACEUTICALS, INC.   |  RESPONSE PHARMACEUTICALS, INC.
ERIC 
 
KELLER 
EXECUTIVE OFFICER, DIRECTOR
NANO TERRA, INC.   |  INFUSION SOFTWARE INC   |  STATELESS, INC.   |  RESPONSE PHARMACEUTICALS, INC.   |  NOVEOME BIOTHERAPEUTICS, INC.   |  RETENSION PHARMACEUTICALS, INC.   |  C2C METALS CORP.   |  URANO ENERGY CORP.
DONALD 
 
OLDS 
DIRECTOR
TELESTA THERAPEUTICS INC.   |  ACASTI PHARMA INC.   |  GOODFOOD MARKET CORP.   |  RETENSION PHARMACEUTICALS, INC.   |  RESPONSE PHARMACEUTICALS, INC.
PAUL 
 
SWEETNAM 
EXECUTIVE OFFICER
SURFACE LOGIX INC   |  RESPONSE PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-06-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2024-06-13 
2022-12-05
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-08 
2022-03-01
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
COLLAGE VENTURE PARTNERS, LLC
316063
NONE
NONE
STONEHAVEN, LLC
118913
NONE
NONE
COLLAGE VENTURE PARTNERS, LLC
316063
NONE
NONE
STONEHAVEN, LLC
118913
NONE
NONE
FLYING CLOUD SECURITIES, LLC
167621
NONE
NONE
CIM SECURITIES, LLC
120852